Sandy Chevrier
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Molecular Biology top 10%
- Gut microbiota and health
- DNA and Nucleic Acid Chemistry
- Cell death mechanisms and regulation
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Polyomavirus and related diseases 2
-
- T-cell and B-cell Immunology 3
- Co-authors
- Romain Boidot (24 shared papers)Frédérique Végran (10 shared papers)François Ghiringhelli (12 shared papers)Pauline Lejault (1 shared paper)S.Y. Cindy Yang (1 shared paper)A. Gordon Robertson (1 shared paper)David Monchaud (1 shared paper)Judy M.Y. Wong (1 shared paper)
- Journals
- Cancer Immunology Research (3 papers)Nature Communications (2 papers)Oncotarget (2 papers)European Journal of Cancer (2 papers)BMC Cancer (1 paper)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
Sandy Chevrier
32 papers receiving 1.6k citations
Sandy Chevrier's Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 366
- Molecular Biology 537
- Cancer Research 58
- Immunology 57
- Genetics 55
Countries citing papers authored by Sandy Chevrier
This map shows the geographic impact of Sandy Chevrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Chevrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Chevrier more than expected).
Fields of papers citing papers by Sandy Chevrier
This network shows the impact of papers produced by Sandy Chevrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Chevrier. The network helps show where Sandy Chevrier may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandy Chevrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer Hit paper breakdown → | 2022 | 552 |
| 2 | A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota Hit paper breakdown → | 2022 | 207 |
| 3 | 2018 | 179 | |
| 4 | 2018 | 154 | |
| 5 | 2019 | 70 | |
| 6 | 2017 | 53 | |
| 7 | 2010 | 41 | |
| 8 | 2016 | 40 | |
| 9 | 2018 | 40 | |
| 10 | 2008 | 39 | |
| 11 | 2013 | 38 | |
| 12 | 2014 | 26 | |
| 13 | 2016 | 26 | |
| 14 | 2011 | 25 | |
| 15 | 2017 | 20 | |
| 16 | 2020 | 19 | |
| 17 | 2021 | 18 | |
| 18 | 2025 | 18 | |
| 19 | 2016 | 17 | |
| 20 | 2022 | 17 |
About Sandy Chevrier
Sandy Chevrier is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (3 papers), T-cell and B-cell Immunology (3 papers), Polyomavirus and related diseases (2 papers), Cancer Genomics and Diagnostics (2 papers), Cell death mechanisms and regulation (2 papers), Nanoparticle-Based Drug Delivery (1 paper) and RNA Research and Splicing (1 paper). The work is most often cited by research in Oncology (366 citations), Molecular Biology (537 citations), Cancer Research (58 citations), Immunology (57 citations) and Genetics (55 citations). Sandy Chevrier has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Romain Boidot, Frédérique Végran, François Ghiringhelli, Pauline Lejault, S.Y. Cindy Yang, A. Gordon Robertson, David Monchaud, Judy M.Y. Wong, Sarab Lizard‐Nacol and Laurent Arnould. Their work appears in journals such as Cancer Immunology Research, Nature Communications, Oncotarget, European Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.